Quarterly statement Q1 2024

January 1 to March 31, 2024

Positive start into the new fiscal year - guidance for 2024 confirmed

Sales up by 4.5% to 136.8 million Euro in the first quarter of 2024 - EBIT margin reaches 24.7%

"The successful start into 2024 forms a solid foundation for the further course of business. Despite ongoing geopolitical and economic uncertainties and temporary inventory adjustments following the end of the allocation, Elmos' business performance is robust, as expected. We are in an excellent position to participate sustainably in the structural growth of the automotive semiconductor market."

Dr. Arne Schneider, CEO of Elmos Semiconductor SE

Key figures

in million Euro unless otherwise indicated

Q1 2024

Q1 2023

Change

Sales

136.8

130.9

4.5%

Gross profit

62.6

59.3

5.6%

in % of sales

45.8%

45.3%

Research & development expenses

16.2

16.0

0.9%

in % vom Umsatz

11.8%

12.2%

Operating income before other operating expenses (-)/ income

31.1

30.7

1.5%

in % of sales

22.8%

23.4%

EBIT

33.8

31.8

6.4%

in % of sales

24.7%

24.3%

Consolidated net income after non-controlling interests

24.6

20.5

19.6%

in % of sales

18.0%

15.7%

Earnings per share (basic) in Euro

1.44

1.20

19.6%

03/31/2024 12/31/2023

Change

Total assets

799.9

812.4

-1.6%

Shareholders' equity

472.9

447.9

5.6%

in % of total assets

59.1%

55.1%

Financial liabilities

118.4

118.7

-0.3%

Liquid assets and securities

58.4

108.3

-46.1%

Net debt

-60.0

-10.4

>100.0%

Q1 2024

Q1 2023

Change

Operating cash flow

-23.1

-1.7

>100.0%

Capital expenditures

20.3

15.2

32.9%

Capital expenditures

14.8%

11.6%

Adjusted free cash flow

-48.9

-18.7

>100.0%

Definitions of selected financial indicators

  • Capital expenditures: Capital expenditures for intangible assets and property, plant and equipment less capitalized development expenses.
  • Adjusted free cash flow: Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment (including payments from changes in the scope of consolidation).

Profit, financial position, as well as assets and liabilities

-> Sales and earnings developed positively in the first quarter of 2024 despite ongoing geopolitical and economic uncertainties.

-> EBIT and EBIT margin increased slightly compared to the same quarter of the previous year.

-> Capital expenditures were at a higher level at the start of the year, as expected.

-> Adjusted free cash flow was primarily influenced by year-end effects on working capital and was therefore negative.

-> The ratio of orders received for the next three months to sales over the past three months, known as the book-to-bill ratio, stood at one at the end of the reporting period.

2

Sales by region

Guidance Fiscal Year 2024 (unchanged as of February 15, 2024)

575.0

34.3%

5.1%

6.9%

53.7%

FY 2023

136.8

Total sales

34.0%

(inmillion Euro)

4.1%

7,0%

54.9%

E.U. Countries

Other

America

Asia/Pacific

Q1 2024

Sales

605 million Euro ±25 million Euro

Operating EBIT margin1

25% ± 2 percentage points

Capital expenditures (in % of sales)2

12% ± 2 percentage points

Operating adjusted free cash flow3

positive and significantly above the previous year's level (-24.3 million Euro)

Assumed average exchange rate

1.10 EUR/USD

  1. EBIT margin excluding effects from the closing of the sale of the Elmos wafer fab to Littelfuse Inc., USA.
  2. Capital expenditures for intangible assets and property, plant and equipment, less capitalized development expenses.
  3. Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment, excluding effects from the closing of the sale of the Elmos wafer fab to Littelfuse Inc., USA.

Explanation of the guidance for fiscal year 2024:

The current outlook is unchanged from the guidance of February 15, 2024.

-> For the 2024 financial year, Elmos expects to generate sales of 605 million Euro ± 25 million Euro and an operating EBIT margin of 25% ± 2 percentage points of sales. The anticipated operating EBIT margin does not include any effects from the closing of the sale of the Elmos wafer fab to Littelfuse Inc., USA, which is expected for the end of December 2024.

-> Following the significant expansion of testing capacities, Elmos expects capital expenditures to decline year on year in 2024. The company therefore anticipates that capital expenditures for property, plant and equipment and intangible assets, less capitalized development costs, will amount to approximately 12% of sales ± 2 percentage points.

-> For fiscal year 2024, Elmos expects positive operating adjusted free cash flow (excluding effects from the closing of the sale of the Elmos wafer fab to Littelfuse Inc., USA) to be significantly higher than in the previous year (-24.3 million Euro).

Current expectations may be affected in particular by geopolitical events such as the war in Ukraine, the conflict in the Middle East, by tighter sanctions and trade restrictions, market turbulence, rising prices, and potential shortages for energy, materials, services, and personnel.

3

Condensed consolidated statement of financial position

Assets | in thousand Euro

03/31/2024

12/31/2023

Equity and liabilities | in thousand Euro

03/31/2024

12/31/2023

Intangible assets

46,862

40,757

Share capital

17,700

17,700

Property, plant and equipment

297,357

292,132

Treasury shares

-579

-579

Securities

4,108

13,422

Additional paid-in capital

19,780

19,613

Investments

1

1

Surplus reserve

102

102

Other financial assets

7,124

8,927

Other equity components

-122

-254

Deferred tax assets

765

656

Retained earnings

435,428

410,857

Non-current assets

356,216

355,895

Equity attributable to owners of the parent

472,308

447,439

Non-controlling interests

578

504

Inventories

224,046

191,526

Equity

472,887

447,943

Trade receivables

85,044

91,018

Securities

14,052

6,748

Financial liabilities

98,905

99,879

Other financial assets

3,242

5,524

Deferred tax liabilities

12,251

9,814

Other receivables

23,845

21,110

Non-current liabilities

111,156

109,693

Income tax assets

254

212

Provisions

27,550

22,735

Cash and cash equivalents

35,849

85,629

Income tax liabilities

75,026

71,839

Assets held for sale

57,311

54,736

Financial liabilities

19,469

18,807

Current assets

443,643

456,503

Trade payables

48,224

97,598

Other liabilities

41,945

40,304

Total assets

799,859

812,398

Liabilities in connection with assets held for sale

3,603

3,480

Current liabilities

215,817

254,763

Liabilities

326,973

364,455

Total equity and liabilities

799,859

812,398

4

Condensed consolidated income statement

Condensed consolidated statement of cash flows

in thousand Euro

Q1 2024

Q1 2023

in thousand Euro

Sales

136,803

130,914

Consolidated net income

Cost of sales

-74,192

-71,626

Depreciation and amortization

Gross profit

62,610

59,288

Losses from disposal of assets

Research and development expenses

-16,164

-16,023

Financial result

Distribution expenses

-7,047

-5,304

Other non-cash income (-)/expenses

Administrative expenses

-8,270

-7,277

Current income tax

Operating income before other operating expenses (-)/ income

31,130

30,684

Expense for stock awards/share matching

Foreign exchange gains

554

443

Changes in net working capital:

Other operating income

2,878

875

Trade receivables

Other operating expenses

-771

-241

Inventories

Earnings before interest and taxes (EBIT)

33,792

31,760

Other assets

Finance income

379

88

Trade payables

Finance expenses

-768

-920

Other provisions and other liabilities

Earnings before taxes

33,403

30,928

Income tax payments (-)/ refunds

Income tax

-8,758

-10,408

Interest paid

thereof current income tax

-7,193

-10,111

Interest received

thereof deferred tax

-1,565

-297

Cash flow from operating activities

Consolidated net income

24,645

20,520

thereof attributable to owners of the parent

24,571

20,543

Capital expenditures for intangible assets

thereof attributable to non-controlling interests

74

-23

Capital expenditures for property, plant and equipment

Payments from disposal of non-current assets

Earnings per share

Euro

Euro

Proceeds from additions to the scope of consolidation

Basic earnings per share

1.44

1.20

Disposal of/ investment in (-) securities

Fully diluted earnings per share

1.44

1.20

Payments for other financial assets

Cash flow from investing activities

Payments from the repayment of financial liabilities to banks

Repayment of liabilities from installment purchase

Repayment of leasing liabilities

Repayment of other financial liabilities

Other changes

Cash flow from financing activities

Decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of reporting period

Cash and cash equivalents at end of reporting period

of which cash and cash equivalents of the disposal group

Q1 2024

24,645

9,915

552

389

-499

7,193

167

5,950

-32,439

-2,452

-39,813

7,089

-4,049

-82

379

-23,056

-8,062

-17,780

20

3

2,123

0

-23,696

-513

0

-388

-280

-1

-1,182

-47,934

34

88,175

40,275

4,426

Q1 2023

20,520

7,916

5

832

297

10,111

176

-7,381

-23,807

-5,906

-3,538

3,964

-4,251

-682

88

-1,656

-1,899

-15,287

143

0

13,131

-26

-3,938

-513

-160

-338

-280

-16

-1,307

-6,901

-99

36,641

29,640

n/a

5

Financial calendar 2024

Quarterly results Q1/20241

May 7, 2024

Annual General Meeting

May 15, 2024

Quarterly results Q2/20241

August 1,

2024

Quarterly results Q3/20241

November 6,

2024

1 The German Securities Trading Act (Wertpapierhandelsgesetz) and the Market Abuse Regulation oblige issuers to announce any information that may have a substantial price impact immediately, irrespective of the financial calendar. Therefore, we cannot rule out having to announce key figures of quarterly and annual results ahead of the dates mentioned above. As we can never rule out changes of dates, we recommend checking them in advance on the website (www.elmos.com).

Contact

Ralf Hoppe | Investor Relations

Phone: + 49 (0) 231-7549-7000

Fax: + 49 (0) 231-7549-111 invest@elmos.com

Elmos Semiconductor SE

Heinrich-Hertz-Straße 1

44227 Dortmund | Germany

Phone: + 49 (0) 231-7549-0

Fax: + 49 (0) 231-7549-149 info@elmos.com | www.elmos.com

Notice

This document is a quarterly statement in accordance with Section 51a Rules and Regulations for the Frankfurter Wertpapierbörse (Börsenordnung für die Frankfurter Wertpapierbörse). For mathematical reasons, tables and references may contain rounding differences to the exact figures (currency units, percentages, etc.).

Forward-looking statements

This report contains forward-looking statements that are based on assumptions and estimates made by the Elmos management. Even though we assume the underlying expectations of our statements to be realistic, we cannot guarantee these expectations will prove right. The assumptions may carry risks and uncertainties, and as a result actual events may differ materially from the forward-looking statements. Among the factors that could cause such differences are changes in general economic and business conditions, fluctuations of exchange rates and interest rates, the introduction of competing products, lack of acceptance of new products, and changes in business strategy. Elmos neither intends nor assumes any obligation to update its statements with respect to future events.

This English translation is provided for convenience only. The German text shall be the sole legally binding version.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Elmos Semiconductor AG published this content on 07 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2024 05:58:05 UTC.